Evolving cancer-niche interactions and therapeutic targets during bone metastasis

被引:66
|
作者
Satcher, Robert L. [1 ]
Zhang, Xiang H. -F. [2 ,3 ,4 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Orthoped Oncol, Houston, TX 77030 USA
[2] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA
[3] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
关键词
RENAL-CELL CARCINOMA; PROSTATIC ACID-PHOSPHATASE; HEMATOPOIETIC STEM-CELLS; DISSEMINATED TUMOR-CELLS; COLONY-STIMULATING FACTOR; PREDICTS POOR-PROGNOSIS; HORMONE-RELATED PROTEIN; BREAST-CANCER; MULTIPLE-MYELOMA; ZOLEDRONIC ACID;
D O I
10.1038/s41568-021-00406-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many cancer types metastasize to bone. This propensity may be a product of genetic traits of the primary tumour in some cancers. Upon arrival, cancer cells establish interactions with various bone-resident cells during the process of colonization. These interactions, to a large degree, dictate cancer cell fates at multiple steps of the metastatic cascade, from single cells to overt metastases. The bone microenvironment may even influence cancer cells to subsequently spread to multiple other organs. Therefore, it is imperative to spatiotemporally delineate the evolving cancer-bone crosstalk during bone colonization. In this Review, we provide a summary of the bone microenvironment and its impact on bone metastasis. On the basis of the microscopic anatomy, we tentatively define a roadmap of the journey of cancer cells through bone relative to various microenvironment components, including the potential of bone to function as a launch pad for secondary metastasis. Finally, we examine common and distinct features of bone metastasis from various cancer types. Our goal is to stimulate future studies leading to the development of a broader scope of potent therapies.
引用
收藏
页码:85 / 101
页数:17
相关论文
共 50 条
  • [1] Evolving cancer–niche interactions and therapeutic targets during bone metastasis
    Robert L. Satcher
    Xiang H.-F. Zhang
    Nature Reviews Cancer, 2022, 22 : 85 - 101
  • [2] New therapeutic targets for cancer bone metastasis
    Krzeszinski, Jing Y.
    Wan, Yihong
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2015, 36 (06) : 360 - 373
  • [3] Emerging therapeutic targets in breast cancer bone metastasis
    Rose, April A. N.
    Siegel, Peter M.
    FUTURE ONCOLOGY, 2010, 6 (01) : 55 - 74
  • [4] Reactive Stroma as Therapeutic Targets in Breast Cancer Bone Metastasis
    Kang, Y.
    CANCER RESEARCH, 2012, 72
  • [5] The potential therapeutic targets to bone pain induced by cancer metastasis
    Wu, Jianguo
    Wei, Yibing
    Shi, Jingsheng
    Chen, Feiyan
    Huang, Guangyong
    Chen, Jie
    Xia, Jun
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2013, 9 (07) : S135 - S141
  • [6] Niche competition and cancer metastasis to bone
    Schuettpelz, Laura G.
    Link, Daniel C.
    JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (04): : 1253 - 1255
  • [7] Are matrix metalloproteinases relevant therapeutic targets for prostate cancer bone metastasis?
    Bonfil, R. D.
    Fridman, R.
    Mobashery, S.
    Cher, M. L.
    CURRENT ONCOLOGY, 2008, 15 (04) : 188 - 192
  • [8] Bone Morphogenetic Proteins and its Receptors; Therapeutic Targets in Cancer Progression and Bone Metastasis?
    Buijs, Jeroen T.
    Petersen, Maj
    van der Horst, Geertje
    van der Pluijm, Gabri
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (11) : 1291 - 1300
  • [9] Novel therapeutic targets for cancer metastasis
    Stoletov, Konstantin
    Beatty, Perrin H.
    Lewis, John D.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (02) : 97 - 109
  • [10] The Endosteal Niche in Breast Cancer Bone Metastasis
    Haider, Marie-Therese
    Smit, Daniel J.
    Taipaleenmaeki, Hanna
    FRONTIERS IN ONCOLOGY, 2020, 10